Legal Representation
Attorney
G Kenneth Smith
USPTO Deadlines
Application History
11 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 1, 2024 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Apr 1, 2024 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Dec 13, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Dec 13, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Sep 13, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 13, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 13, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 11, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 30, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Dec 29, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 6, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Pharmaceutical products development
First Use Anywhere:
Jun 1, 2022
First Use in Commerce:
Jun 1, 2022
Additional Information
Design Mark
The mark consists of The mark consists of VP Virpax Pharmaceuticals with human head and design in brain section of the head and including spinal cord.
Color Claim
The color(s) blue, gray is/are claimed as a feature of the mark.
Classification
International Classes
042